Cover Image
市場調查報告書

賀爾蒙補充療法(HRT)的全球市場

Hormone Replacement Therapy (HRT)

出版商 Global Industry Analysts, Inc. 商品編碼 222499
出版日期 內容資訊 英文 198 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
賀爾蒙補充療法(HRT)的全球市場 Hormone Replacement Therapy (HRT)
出版日期: 2016年05月01日 內容資訊: 英文 198 Pages
簡介

本報告著眼於賀爾蒙補充療法的全球市場,直接取材及依據從網路上資料、情報獲得的市場資料和動向分析,另外依地區(美國、加拿大、歐洲、亞洲太平洋、中南美及其他)提供2012–2020年期間交易量的業績和預測,彙整過去6年市場的經緯及加入市場主要40家精銳企業的最新概況,內容綱要摘記如下:

第1章 介紹、調查方法、產品的定義

  • 調查的可靠性和報告的界限
  • 免責事項
  • 數據的解釋和製作報告的水準
    • 定量技術及分析法
  • 產品的定義和調查的範圍

第2章 實施摘要

  • 概觀
    • 賀爾蒙補充療法(HRT) – 序
    • 依地區區分
    • 現狀及未來分析
  • 產業概要
    • 更年期障礙和賀爾蒙補充療法 – 介紹
    • 代表性雌激素療法的概要
    • Women's Health Initiative(WHI)調查 –對賀爾蒙補充療法市場的大打擊
    • 新千禧年賀爾蒙補充療法爭論的進化
    • 上次調查數據的再評價 – 對賀爾蒙補充療法的需求有復活的希望
    • IMS(International Menopause Society)朝提高賀爾蒙補充療法明瞭性之路訂定統一指針
    • 更年期統計 – 機會指標
    • 更年期症狀存在的民族差異
  • 市場動向和課題
    • 依據較少數希望處理女性人口而規定的市場規模
    • 安全性問題:對賀爾蒙補充療法市場的大妨礙
    • 持續面臨法律困境的製造廠
    • 局部使用雌激素 – 安全性較高且有效
    • 提供刺激機會的經皮賀爾蒙補充療法產品
    • 植物性雌激素 – 是對更年期症狀新的特效藥嗎
    • 喚起大眾關心的減重和更年期障礙的關聯性
    • 大豆及其他植物性雌激素的影響度 – 檢查現實性
    • 增加話題性的生物學同質性藥劑
    • 生物學同質性荷爾蒙 – 是取代合成賀爾蒙補充療法、安全的天然物質嗎
    • 賀爾蒙補充療法以消費者為對像之直接廣告 – 功與過的評價
  • 競爭環境
    • 賦予賀爾蒙補充療法全球市場特徵的激烈競爭 – 競爭企業•產品事例集
  • 療法簡介 – 驗證具代表性的研究事例
  • 產品概要
    • 何謂賀爾蒙
    • 何謂更年期
    • 更年期的症狀和不足
    • 賀爾蒙補充療法產品
    • 使用賀爾蒙補充療法的理由
    • 賀爾蒙補充療法的禁忌
    • 歷史的變遷
    • 賀爾蒙療法的優點
    • 賀爾蒙療法的風險
    • 賀爾蒙補充療法之賀爾蒙療法及效果
    • 更年期賀爾蒙補充療法潛在的優點和風險
    • 雌激素單體、黃體激素單體及併用後各自一般性的副作用和非一般性的副作用
    • 潛在的問題
    • 心血管疾病
    • 子宮內膜癌
    • 乳癌
    • 肺癌
    • 躁鬱症
    • 卵巢癌
    • 給藥路徑
    • 全身療法
    • 生物同質性荷爾蒙補充療法(BHRT)
    • 歷史背景
    • 超過證明能力的索賠數
    • 其他替代療法
    • 處方藥
    • 植物學
    • 心和身體的治療
    • 運動和減重
  • 產品銷售•認可
  • 最近的產業動向
  • 全球主要企業
  • 全球市場展望

第3章 市場

  • 美國
  • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 其他國家
  • 亞洲太平洋
  • 中南美
  • 其他地區

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6453

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 40 companies including many key and niche players such as -

Abbott Laboratories
AbbVie, Inc.
Allergan plc
Bayer Pharma AG
Hisamitsu Pharmaceutical Co., Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definition and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • HRT - A Prelude
  • The Regional Divide
  • Current and Future Analysis

2. INDUSTRY OVERVIEW

  • An Introduction to Menopause and Hormone Replacement Therapy
  • An Overview of Select Estrogen Therapy Approaches
  • WHI Study- A Major Blow to the HRT Market
  • The HRT Controversy Evolution in the New Millennium
  • Reappraisal of Data from Previous Studies - A Hope for Resurgence in HRT Demand
  • IMS Consensus Guidelines Paving Way for More Clarity of HRT
  • Menopause Statistics - An Opportunity Indicator
  • Ethnic Differences Exist in Menopausal Symptoms

3. MARKET TRENDS & ISSUES

  • Market Size Restricted by Lesser Number of Women Opting for Treatment
  • Safety Issues: A Major Deterrent to the HRT Market
  • Manufacturers Continue to Face Legal Challenges
  • Topical Estrogens - More Safe and Effective
  • Transdermal HRT Products Present Exciting Opportunities
  • Phytoestrogens - The New Panacea for Menopausal Symptoms?
  • Diet Link to Menopause Symptoms Raises Interest
  • Impact of Soy and Other Phytoestrogens - A Reality Check
  • The Growing Buzz around Bioidentical Drugs
  • Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT?
    • List of Bio-identical Products Used in Conventional HRT
  • Direct-to-Consumer Advertising for HRT - A Mixed Bag

4. COMPETITIVE LANDSCAPE

  • Intense Competition Marks the Global HRT Market
    • Table 1: Global Sales of Select HRT Products (In US$ Million) (includes corresponding Graph/Chart)
  • The Premarin Saga
  • Health Risks Tarnish Premarin's Image
    • Table 2: Annual Sales of Premarin Family: 2002-2013 (includes corresponding Graph/Chart)
  • Pfizer Seeks Refuge in Line Extensions
  • Better Safety Profile for Duavee - A Shot in the Arm for Pfizer
  • Estrace Cream Drives Revenue Gains in Warner Chilcott's HRT Portfolio
    • Table 3: Annual Sales of Estrace Cream: 2010-2013 (includes corresponding Graph/Chart)
    • Table 4: Annual Sales of Warner Chilcott's HRT Portfolio - Estrace Cream, Estrace Tablets, femhrt and Femring - in US$ Million for Years 2010 & 2011 (includes corresponding Graph/Chart)
  • New Drug Buoys Novo Nordisk's HRT Portfolio
  • Estriol: The Next Generation Estrogen Therapy?
  • What Makes Estriol Work?
  • Topical Estriol - More Promising in Safety
  • Estriol - Used More Commonly Outside the US
  • Entry of Generics Threatens Market Growth Prospects
  • Select Hormone Therapies for Post Menopausal Women by Year of Patent Expiry
  • Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions
  • Select Hormone Therapies for Treatment of Postmenopausal Symptoms by Generic Manufacturers
  • Are Non-Hormonal Therapies A Threat to HRT?
  • Earlier Failures Induce Lethargy in Non-Hormonal Therapies
  • Menerba: A Promising Non-Hormone Therapy for Menopausal Hot Flashes

5. THERAPY PROFILE - A REVIEW OF SELECT RECENT STUDIES CONDUCTED

  • Researchers at Yale University Discover Discontinuation HRT May Lead to Premature Deaths
  • Bioidenticals versus Synthetic Hormone Replacement Therapy Agents
  • Studies at University of Sydney Researchers Reveal the Safety of Short-Term Unopposed Estrogens
  • US Researchers Reveal HRT Risks May be Dependent on Weight and Other Factors
  • Studies Prove HRT to Lower Risk of Pancreatic Cancer
  • University of Texas Reveal HRT Linked to Risks of Kidney Stones
  • Researchers at the Sundsvall Hospital Demonstrate Increased Incidence of Cataract Development in Women Undergoing HRT
  • Researchers at University of Southern California Demonstrate Estrogen Replacement Therapies Lower Stress Levels in Older Women
  • Studies at Uppsala University Hospital Demonstrate HRT is Associated with Improved Muscle Functioning in Postmenopausal women
  • Finnish Study Reveals HRT Usage Assist in the Treatment of Hot Flashes in Post Menopausal Women
  • Researchers at Johns Hopkins University Demonstrate Women Undergoing Hormone Therapy Less Prone to Alzheimer's Disease
  • French Study Reveals Hormone Replacement Pills May Affect Gall Bladder
  • Danish Studies Proves HRT Lowers Risk of Heart Attack and Heart Failure

6. PRODUCT OVERVIEW

  • What are Hormones?
  • What is Menopause?
  • Menopause Symptoms and Complaints
  • Introduction to Hormone Replacement Therapy
  • HRT Products
    • Estrogen
    • Progestins
      • Types of HRT
  • Why HRT?
    • Milestones and Downfalls in the Hormone Replacement Therapy (HRT) Market
  • Contraindications of HRT
  • Historical Progression
    • Advantages and Disadvantages of Using HRT
  • Benefits of Hormone Therapy
    • Relief from Vasomotor Symptoms
    • Vaginal Symptoms
    • Improvement in Sexual Functioning
    • Urinary Health
    • Management of Variations in Body Weight/ Mass
    • Ensuring Quality of Life
    • Osteoporosis
    • Diabetes Mellitus (DM)
    • Impact on Overall Mortality
    • Treatment of Premature Menopause
  • Risks Involved in Hormone Therapy
  • Hormone Therapies in HRT and their Effect
  • Potential Benefits and Risks of HRT in Menopausal Symptoms
  • Common and Less Common Side Effects of Using Estrogen-alone, Progesterone-alone or Combination Therapies
  • Potential Issues
  • Cardiovascular Problems
    • Coronary Heart Disease (CHD)
    • Stroke
    • Venous Thromboembolism (VTE)
  • Endometrial Cancer
  • Breast Cancer
    • Estrogen-Progestogen Therapy
    • Estrogen Therapy
  • Lung Cancer
  • Depression and Mood Swings
  • Ovarian Cancer
  • Routes of Administration
  • Systemic Treatment
    • Pills
      • Advantages and Disadvantages of Oral HRT
    • Vaginal Estrogen Ring
    • Transdermal Estrogen Skin Patches
    • Localized Treatment
      • Vaginal Estrogen Tablets
      • Estrogen Creams
      • Intrauterine Progestin System (IUS)
      • Lower Dose Vaginal Estrogen Ring
      • Vaginal Progesterone Gel
    • Implants
      • Advantages and Disadvantages of HRT Implants
  • Bioidentical Hormone Replacement Therapy (BHRT)
  • Historical Background
  • More Claims than Evidence
  • Other Alternatives
  • Prescription Medication
    • Gabapentin
    • Clonidine
    • SNRIs and SSRIs
  • Botanicals
    • Black Cohosh
    • Phytoestrogens (Isoflavones)
    • Other Botanical Products
    • Non-botanical Supplements
  • Mind/Body therapies
  • Exercise and Diet

7. PRODUCT INTRODUCTIONS/APPROVALS

  • Pfizer Receives FDA Approval for DUAVEE(tm) for Treatment of Vasomotor Symptoms
  • Noven Pharmaceuticals Launches Brisdelle(tm) Capsules
  • Lawley Pharmaceuticals Launches Profeme progesterone Bioidentical Hormone Replacement Cream
  • Bayer Receives FDA Approval for Low-Dose ANGELIQ(r) Tablets
  • Noven Pharmaceuticals Receives USFDA Approval for Minivelle(tm)
  • Mylan Pharmaceuticals Introduces Letrozole Tablets
  • Novo Nordisk Unveils Vagifem(r) 10μg
  • Amgen Obtains FDA Approval for Prolia in Treating Postmenopausal Women at Greater Risk of Osteoporosis

8. RECENT INDUSTRY ACTIVITY

  • Actavis Takes Over Warner Chilcott
  • US FDA Rejects SEFELSA(tm) from Depomed for Treatment of Menopause Symptoms
  • US FDA Advisory Committee Rejects Noven Pharmaceuticals' LDMP, a Low-Dose Mesylate Salt of Paroxetine
  • Piramal to Expand its Hormone Product Capacity in the UK
  • BioSante Pharmaceuticals Merges with ANI Pharmaceuticals
  • Biovive Medicine Establishes New Site for BHRT Production in Boulder
  • TherapeuticsMD Commences Phase I Clinical Trial of Estradiol Vagicap(tm)
  • US FDA Accepts TherapeuticsMD's IND for TX12-004HR
  • TherapeuticsMD Files Patent Application for Proprietary New Formulation Technologies
  • Noven Takes over Commercial Rights to Minivelle(tm) from Novogyne Pharmaceuticals
  • Pfizer Halts Development of PRISTIQ(r) for Treatment of Vasomotor Symptoms
  • Teva Completes Takeover of Theramex
  • Pfizer Global Manufacturing to Reconfigure Global Plant Network
  • Watson Enters into Agreement to Acquire US rights of CLI's Bioadhesive Progesterone Gel
  • Solvay Divests Pharmaceutical Business

9. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories (US)
  • AbbVie, Inc. (US)
  • Actavis Plc (Ireland)
  • Bayer Pharma AG (Germany)
  • Bayer Pharma's Hormone Replacement Therapy Product Pipeline
  • Hisamitsu Pharmaceutical Co., Inc. (Japan)
  • Noven Pharmaceuticals, Inc. (US)
  • Merck Sharp & Dohme Corp. (UK)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Orion Corporation (Finland)
  • Pfizer, Inc. (US)
  • Rottapharm Madaus (Italy)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • TherapeuticsMD, Inc. (US)
  • Upsher-Smith Laboratories, Inc. (US)

10. GLOBAL MARKET PERSPECTIVE

    • Table 5: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 6: World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 7: World 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • HRT Market in the US - An Overview
      • List of FDA Approved Drugs for Treatment of Menopause Symptoms by Year of Approval
      • List of FDA-Approved Prescription Estrogen- Only Drugs for Preventing Postmenopausal Osteoporosis
      • List of FDA-Approved Prescription Estrogen- Progestin Combination Drugs for Preventing Postmenopausal Osteoporosis
      • List of FDA-Approved Oral Estrogen Therapy Products for Use in Postmenopausal Indications
      • List of FDA-Approved Progestogens
    • The Menopause Opportunity
    • Table 8: US Female Population Percentage Distribution by Age Group: 2013 (includes corresponding Graph/Chart)
    • Impact of the WHI Study
    • Increasing Preference for Topical Vaginal Products
    • Rising Interest in Low-Dose Hormone Therapies to Lead Market Growth
      • Low-Dose Hormone Replacement Therapy Formulations of Estrogens and Estrogen- Progestin Combinations Available in the United States
    • Are Custom Compounded Bioidenticals Products Better?
      • List of FDA-Approved Bioidentical Hormones
      • Bioidenticals Remains a Lethargic Market in the US
      • Regulatory Scenario for BHRT in the US
      • Issues with Approved Bioidenticals
    • Product Launches/Approvals
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 9: The US Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 10: The US Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Canada - The Birth Place of Estrogens
    • Current Market Scenario
    • The Fallout of the WHI Study
    • Table 11: Canadian Female Population Estimates by Age Group: 2013 (includes corresponding Graph/Chart)
      • List of Approved Prescription Estrogen-Only Drugs for Preventing Postmenopausal Osteoporosis in Canada
      • List of Approved Prescription Estrogen- Progestin Combination Drugs for Preventing Postmenopausal Osteoporosis in Canada
      • List of Approved Topical and Transdermal Estrogens Products in Canada
      • List of Approved Vaginal Estrogen Therapy Products in Canada
      • List of Approved Oral Estrogen Therapy Products for Use in Postmenopausal Indications in Canada
  • B. Market Analytics
    • Table 12: Canadian Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 13: Canadian Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Growing Demand for Topical and Transdermal HRT
    • European Medicines Agency Imposes New Restrictions on Linoladiol HN and Linoladiol N Estradiol Creams
  • B. Market Analytics
    • Table 14: European Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 15: European Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 16: European 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • A Peek into the HRT Prescription Practices in France
  • B. Market Analytics
    • Table 17: French Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 18: French Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Bayer Pharma AG - A Major Germany- Based Player
      • Bayer Pharma's Hormone Replacement Therapy Product Pipeline
  • B. Market Analytics
    • Table 19: German Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 20: German Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3c. ITALY

  • A. Market Analysis
    • Current & Future Analysis
    • Rottapharm Madaus - A Major Italy-based Regional Player
  • B. Market Analytics
    • Table 21: Italian Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 22: Italian Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Post Menopausal Symptoms in British Women
    • British Menopause Society and Women's Health Concern Revises Recommendations on HRT
      • List of the Hormone Replacement Therapy Products Available in the UK
      • List of HRT Products Available in the UK by Format
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 23: The UK Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 24: The UK Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • HRT Prescription Status in Spain
  • B. Market Analytics
    • Table 25: Spanish Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 26: Spanish Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

3f. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 27: Rest of European Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 28: Rest of European Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Focus on Select Regional Markets
      • Australia
      • Dwindling Options for Estrogen Patients - A Growing Concern
      • Japan
      • Japan - A Small yet Growing Market for HRT
      • Menopausal Characteristics and Impact of Diet
    • Hisamitsu Pharmaceutical Co., Inc. - A Major Japan-Based HRT Manufacturer
  • B. Market Analytics
    • Table 29: Asia-Pacific Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 30: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

5. LATIN AMERICA

  • Market Analysis
    • Table 31: Latin American Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 32: Latin American Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 33: Rest of World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Rest of World Historic Review for Hormone Replacement Therapy (HRT) Market - Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top